Get the Stockscreener App
23.25
3.29%
-0.79
Surrozen Inc stock is traded at $23.25, with a volume of 246.45K.
It is down -3.29% in the last 24 hours and down -15.27% over the past month.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
See More
Previous Close:
$24.04
Open:
$24.18
24h Volume:
246.45K
Relative Volume:
2.25
Market Cap:
$269.94M
Revenue:
$7.49M
Net Income/Loss:
$-360.50M
P/E Ratio:
-0.5626
EPS:
-41.3227
Net Cash Flow:
$-33.68M
1W Performance:
-0.51%
1M Performance:
-15.27%
6M Performance:
+8.19%
1Y Performance:
+134.85%
1-Day Range:
$22.49
$25.31
1-Week Range:
$21.99
$25.59
52-Week Range:
$8.00
$35.00
Surrozen Inc Stock (SRZN) Company Profile
Name
Surrozen Inc
Sector
Industry
Phone
650-475-2820
Address
171 OYSTER POINT BLVD, SOUTH SAN FRANCISCO
Compare SRZN vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRZN
Surrozen Inc
|
23.25 | 269.94M | 7.49M | -360.50M | -33.68M | -41.32 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Surrozen Inc Stock (SRZN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-26 | Initiated | TD Cowen | Buy |
| Feb-19-26 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-30-25 | Initiated | H.C. Wainwright | Buy |
| Jan-03-25 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Sep-15-21 | Initiated | Guggenheim | Buy |
| Sep-07-21 | Initiated | Stifel | Buy |
View All
Surrozen Inc Stock (SRZN) Latest News
Discipline and Rules-Based Execution in SRZN Response - Stock Traders Daily
Surrozen Inc (SRZN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Surrozen Inc (SRZN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Surrozen Inc (SRZN) Institutional Confidence - TradingKey
Surrozen Inc (SRZNW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Surrozen Inc (SRZNW) Institutional Confidence - TradingKey
Surrozen Inc (SRZNW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Surrozen Inc (SRZNW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Surrozen Inc (SRZNW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Surrozen Inc (SRZN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Surrozen Inc (SRZNW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Surrozen Inc (SRZNW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Surrozen Inc (SRZNW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
SRZN Q1 2026 Earnings: Massive EPS Miss Amid No RevenueEarnings Per Share - newsline.com
Surrozen Inc (SRZN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Surrozen Inc (SRZN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Surrozen Inc (SRZN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Surrozen Inc (SRZN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Surrozen (SRZN) CFO acquires 607 shares through 2021 employee stock purchase plan - Stock Titan
Surrozen (SRZN) EVP Li Yang gets 1,666 ESPP shares, now holds 18,882 - Stock Titan
Surrozen (SRZN) COO adds 1,666 shares through 2021 employee stock purchase plan - Stock Titan
Surrozen (SRZN) CEO awarded 1,622 ESPP shares at $8.11, now holds 18,175 - Stock Titan
SRZN Q1 2026 Earnings: Significant EPS Miss Reflects Operational ChallengesPeak Earnings Alert - newsline.com
Surrozen Inc. (SRZN) Q1 2026 Earnings: Significant EPS Miss Amidst Operational UpdatesEarnings Whisper Number - newsline.com
Surrozen Warrants (SRZNW) Hold Steady at $0.02 Amidst Minimal MovementCovered Call ETF - newsline.com
SRZN Q1 2026 Earnings: Significant EPS Miss Amid Sharp Stock RallyGeographic Revenue Trends - newsline.com
Surrozen Warrant (SRZNW) Holds at $0.02 as Trading Action Remains MutedUnusual Call Volume - newsline.com
Surrozen Inc. Warrant (SRZNW) Stabilizes at $0.02 Amid Minimal Trading ActivityPrice Surge Stocks - newsline.com
Surrozen Inc. Warrant (SRZNW): Price Stability at $0.02 Amid Minimal TradingNaked POC - newsline.com
SRZN Q1 2026 Earnings: Massive EPS Miss as Losses WidenFull Year Guidance - newsline.com
SRZN Q1 2026 Earnings: Dramatic EPS Miss of -945.97% Raises ConcernsProfit Warning Alert - newsline.com
Surrozen Warrant (SRZNW) Holds Flat at $0.02 as Trading Remains StagnantNaked POC - newsline.com
Surrozen Inc. Warrant (SRZNW) Surges 23% Amid Thin Trading – Key Levels to WatchBPI Bull Confirmed - The Legal Advocate
Surrozen Inc. (SRZN) Holds Steady Near Support as Consolidation ContinuesStop Hunt - The Legal Advocate
(SRZN) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Total debt per share of Surrozen, Inc. – NASDAQ:SRZN - TradingView
Surrozen Inc. (SRZN) Edges Higher as Stock Tests Key Resistance Amid Low VolumeNegative Gamma - newsline.com
Surrozen Warrants (SRZNW) Plummet 16% to $0.02 – Evaluating Potential Risks and LevelsInsider Selling Alerts - The Legal Advocate
Number of shareholders of Surrozen, Inc. – NASDAQ:SRZN - TradingView
H.C. Wainwright Maintains Surrozen(SRZN.US) With Buy Rating, Maintains Target Price $44 - Moomoo
Surrozen Q1 2026 Earnings: Staggering EPS Miss of -$11.65 Versus Estimate; Stock Declines 2.66%Non-GAAP Earnings - Newser
Surrozen Inc. (SRZN) Q1 2026 Earnings: Significant EPS Miss Reflects Ongoing Clinical-Stage Spending; No Revenue ReportedEBITDA Estimate Trend - The Legal Advocate
Surrozen Inc. (SRZN) Q1 2026 Earnings: EPS Misses Estimates by a Wide Margin; Stock Edges HigherCommunity Watchlist Picks - Newser
What Does TCG Crossover GP II's Recent Buying Spree Mean for Surrozen (SRZN) - Kavout
We Think Surrozen (NASDAQ:SRZN) Can Afford To Drive Business Growth - Moomoo
Surrozen (SRZN) director and 10% owner receives options on 5,550 shares - Stock Titan
Surrozen (SRZN) major holder The Column Group discloses stakes up to 29.3% - Stock Titan
Surrozen (SRZN) Q1 2026 Results Miss Estimates — EPS $-11.65 vs $-1.11Top Trending Breakouts - Newser
We're Not Very Worried About Surrozen's (NASDAQ:SRZN) Cash Burn Rate - Yahoo Finance
How (SRZN) Movements Inform Risk Allocation Models - Stock Traders Daily
Surrozen (SRZN) Drops -5.76% — Key Support at $26.74 2026-05-17Live Trade Sharing - Newser
Surrozen Inc Stock (SRZN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.74%
1.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):